Status:
COMPLETED
Study Evaluating Betaferons Safety and Tolerability In Pediatric Patients With Multiple Sclerosis
Lead Sponsor:
Bayer
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
12-16 years
Brief Summary
Multiple Sclerosis (MS) is mainly known as a disease of young to middle adulthood but approximately 5% of all MS cases worldwide involve children that are younger than 16 years. The aim of care of ch...
Eligibility Criteria
Inclusion
- Treatment naive children and adolescents of 12 to 16 years of age at inclusion with a diagnosis of RRMS according to revised McDonald or Poser criteria and decision taken by the investigator to treat with Betaferon. The local Betaferon product information must be considered.
Exclusion
- Contraindications stated in the local Betaferon product information; warnings and precautions must be considered.
Key Trial Info
Start Date :
December 17 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT00963833
Start Date
December 17 2009
End Date
September 1 2016
Last Update
July 12 2017
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Austria
2
Many Locations, Belgium
3
Many Locations, Finland
4
Many Locations, Germany